|
1
|
Stewart BW and Wild CP: World Cancer
Report 2014. International Agency for Research on Cancer (IARC)
Publications; Lyon, France: 2014, http://www.iarc.fr/en/publications/books/wcr/index.php
|
|
2
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray, F: Cancer incidence and mortality worldwideIARC CancerBase
no. 11. 2012, IARC Press; Lyon:
|
|
3
|
US Mortality Data, . 2006.National Centre
for Health Statistics. Centres for Disease Control and Prevention.
2009.
|
|
4
|
Linet MS, Ries LA, Smith MA, Tarone RE and
Devesa SS: Cancer surveillance series: Recent trends in childhood
cancer incidence and mortality in the United States. J Natl Cancer
Inst. 91:1051–1058. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: European Organisation for Research and Treatment of
Cancer Brain Tumor and Radiotherapy Groups; National Cancer
Institute of Canada Clinical Trials Group: Radiotherapy plus
concomitant and adjuvant temozolomide for glioblastoma. N Engl J
Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sawin PD, Hitchon PW, Follett KA and
Torner JC: Computed imaging-assisted stereotactic brain biopsy: A
risk analysis of 225 consecutive cases. Surg Neurol. 49:640–649.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Samadani U, Stein S, Moonis G, Sonnad SS,
Bonura P and Judy KD: Stereotactic biopsy of brain stem masses:
Decision analysis and literature review. Surg Neurol. 66:484–490;
discussion 491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CC, Hsu PW, Erich Wu TW, Lee ST,
Chang CN, Wei KC, Chuang CC, Wu CT, Lui TN, Hsu YH, et al:
Stereotactic brain biopsy: Single center retrospective analysis of
complications. Clin Neurol Neurosurg. 111:835–839. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liew CC, Ma J, Tang HC, Zheng R and
Dempsey AA: The peripheral blood transcriptome dynamically reflects
system wide biology: A potential diagnostic tool. J Lab Clin Med.
147:126–132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohr S and Liew CC: The peripheral-blood
transcriptome: New insights into disease and risk assessment.
Trends Mol Med. 13:422–432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gladkevich A, Nelemans SA, Kauffman HF and
Korf J: Microarray profiling of lymphocytes in internal diseases
with an altered immune response: Potential and methodology.
Mediators Inflamm. 2005:317–330. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hotamisligil GS: Inflammation and
metabolic disorders. Nature. 444:860–867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liew CC: Methods for the detection of gene
transcripts in blood and uses thereof. United States patent US
20040014059. Jan 22–2004.
|
|
17
|
Marshall KW, Mohr S, Khettabi FE, Nossova
N, Chao S, Bao W, Ma J, Li XJ and Liew CC: A blood-based biomarker
panel for stratifying current risk for colorectal cancer. Int J
Cancer. 126:1177–1186. 2010.PubMed/NCBI
|
|
18
|
Han M, Liew CT, Zhang HW, Chao S, Zheng R,
Yip KT, Song ZY, Li HM, Geng XP, Zhu LX, et al: Novel blood-based,
five-gene biomarker set for the detection of colorectal cancer.
Clin Cancer Res. 14:455–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yip KT, Das PK, Suria D, Lim CR, Ng GH and
Liew CC: A case-controlled validation study of a blood-based
seven-gene biomarker panel for colorectal cancer in Malaysia. J Exp
Clin Cancer Res. 29:128–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsuang MT, Nossova N, Yager T, Tsuang MM,
Guo SC, Shyu KG, Glatt SJ and Liew CC: Assessing the validity of
blood-based gene expression profiles for the classification of
schizophrenia and bipolar disorder: A preliminary report. Am J Med
Genet B Neuropsychiatr Genet 133B. 1–5. 2005. View Article : Google Scholar
|
|
21
|
Glatt SJ, Everall IP, Kremen WS, Corbeil
J, Sásik R, Khanlou N, Han M, Liew CC and Tsuang MT: Comparative
gene expression analysis of blood and brain provides concurrent
validation of SELENBP1 up-regulation in schizophrenia. Proc Natl
Acad Sci USA. 102:15533–15538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaushik N, Fear D, Richards SC, McDermott
CR, Nuwaysir EF, Kellam P, Harrison TJ, Wilkinson RJ, Tyrrell DA,
Holgate ST, et al: Gene expression in peripheral blood mononuclear
cells from patients with chronic fatigue syndrome. J Clin Pathol.
58:826–832. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Y, Schapiro MB, Franz DN, Patterson
BJ, Hickey FJ, Schorry EK, Hopkin RJ, Wylie M, Narayan T, Glauser
TA, et al: Blood expression profiles for tuberous sclerosis complex
2, neurofibromatosis type 1, and Downs syndrome. Ann Neurol.
56:808–814. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang Y, Gilbert DL, Glauser TA, Hershey AD
and Sharp FR: Blood gene expression profiling of neurologic
diseases: A pilot microarray study. Arch Neurol. 62:210–215. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du X, Tang Y, Xu H, Lit L, Walker W,
Ashwood P, Gregg JP and Sharp FR: Genomic profiles for human
peripheral blood T cells, B cells, natural killer cells, monocytes,
and polymorphonuclear cells: Comparisons to ischemic stroke,
migraine, and Tourette syndrome. Genomics. 87:693–703. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Borovecki F, Lovrecic L, Zhou J, Jeong H,
Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, et al:
Genome-wide expression profiling of human blood reveals biomarkers
for Huntington's disease. Proc Natl Acad Sci USA. 102:11023–11028.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maes OC, Xu S, Yu B, Chertkow HM, Wang E
and Schipper HM: Transcriptional profiling of Alzheimer blood
mononuclear cells by microarray. Neurobiol Aging. 28:1795–1809.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liebner S, Fischmann A, Rascher G, Duffner
F, Grote EH, Kalbacher H and Wolburg H: Claudin-1 and claudin-5
expression and tight junction morphology are altered in blood
vessels of human glioblastoma multiforme. Acta Neuropathol.
100:323–331. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wolburg H, Wolburg-Buchholz K, Kraus J,
Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W
and Engelhardt B: Localization of claudin-3 in tight junctions of
the blood-brain barrier is selectively lost during experimental
autoimmune encephalomyelitis and human glioblastoma multiforme.
Acta Neuropathol. 105:586–592. 2003.PubMed/NCBI
|
|
30
|
Noell S, Fallier-Becker P, Beyer C, Kröger
S, Mack AF and Wolburg H: Effects of agrin on the expression and
distribution of the water channel protein aquaporin-4 and volume
regulation in cultured astrocytes. Eur J Neurosci. 26:2109–2118.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wolburg H, Noell S, Wolburg-Buchholz K,
Mack A and Fallier-Becker P: Agrin, aquaporin-4, and astrocyte
polarity as an important feature of the blood-brain barrier.
Neuroscientist. 15:180–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Noell S, Fallier-Becker P, Deutsch U, Mack
AF and Wolburg H: Agrin defines polarized distribution of
orthogonal arrays of particles in astrocytes. Cell Tissue Res.
337:185–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saadoun S, Papadopoulos MC, Davies DC,
Krishna S and Bell BA: Aquaporin-4 expression is increased in
oedematous human brain tumors. J Neurol Neurosurg Psychiatry.
72:262–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Warth A, Kröger S and Wolburg H:
Redistribution of aquaporin-4 in human glioblastoma correlates with
loss of agrin immunoreactivity from brain capillary basal laminae.
Acta Neuropathol. 107:311–318. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Larsson HB, Stubgaard M, Frederiksen JL,
Jensen M, Henriksen O and Paulson OB: Quantitation of blood-brain
barrier defect by magnetic resonance imaging and gadolinium-DTPA in
patients with multiple sclerosis and brain tumors. Magn Reson Med.
16:117–131. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wolburg H, Noell S, Fallier-Becker P, Mack
AF and Wolburg-Buchholz K: The disturbed blood-brain barrier in
human glioblastoma. Mol Aspects Med. 33:579–589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lantos PL, VandenBerg SR and Kleihues P:
Tumors of the nervous systemGreenfields neuropathology. Graham DI
and Lantos PL: Arnold; London: pp. 583–879. 1996
|
|
38
|
Brightman MW and Reese TS: Junctions
between intimately apposed cell membranes in the vertebrate brain.
J Cell Biol. 40:648–677. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peters A, Palay SL and Webster H: The Fine
Structure of the Nervous System. 3nd. Oxford University Press; New
York: 1991
|
|
40
|
Dinda AK, Sarkar C, Roy S, Kharbanda K,
Mathur M, Khosla AK and Banerji AK: A transmission and scanning
electron microscopic study of tumoral and peritumoral microblood
vessels in human gliomas. J Neurooncol. 16:149–158. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sage MR and Wilson AJ: The blood-brain
barrier: An important concept in neuroimaging. AJNR Am J
Neuroradiol. 15:601–622. 1994.PubMed/NCBI
|
|
42
|
Pantel K and Alix-Panabières C:
Circulating tumour cells in cancer patients: Challenges and
perspectives. Trends Mol Med. 16:398–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pantel K, Alix-Panabières C and Riethdorf
S: Cancer micrometastases. Nat Rev Clin Oncol. 6:339–351. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Macarthur KM, Kao GD, Chandrasekaran S,
Alonso-Basanta M, Chapman C, Lustig RA, Wileyto EP, Hahn SM and
Dorsey JF: Detection of brain tumor cells in the peripheral blood
by a telomerase promoter-based assay. Cancer Res. 74:2152–2159.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao F, Cui Y, Jiang H, Sui D, Wang Y,
Jiang Z, Zhao J and Lin S: Circulating tumor cell is a common
property of brain glioma and promotes the monitoring system.
Oncotarget. Aug 8–2016.(Epub ahead of print). doi:
10.18632/oncotarget.11114.
|
|
46
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lavon I, Refael M, Zelikovitch B, Shalom E
and Siegal T: Serum DNA can define tumor-specific genetic and
epigenetic markers in gliomas of various grades. Neuro Oncol.
12:173–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Boisselier B, Gállego Pérez-Larraya J,
Rossetto M, Labussière M, Ciccarino P, Marie Y, Delattre JY and
Sanson M: Detection of IDH1 mutation in the plasma of patients with
glioma. Neurology. 79:1693–1698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Balańa C, Carrato C, Ramírez JL, Cardona
AF, Berdiel M, Sánchez JJ, Tarón M, Hostalot C, Musulen E, Ariza A,
et al: Tumour and serum MGMT promoter methylation and protein
expression in glioblastoma patients. Clin Transl Oncol. 13:677–685.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wakabayashi T, Natsume A, Hatano H, Fujii
M, Shimato S, Ito M, Ohno M, Ito S, Ogura M and Yoshida J: p16
promoter methylation in the serum as a basis for the molecular
diagnosis of gliomas. Neurosurgery. 64:455–461; discussion 461–462.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Manterola L, Guruceaga E, Gállego
Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S,
Diez-Valle R, Segura V, Samprón N, Barrena C, et al: A small
noncoding RNA signature found in exosomes of GBM patient serum as a
diagnostic tool. Neuro Oncol. 16:520–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu J, Li L and Jiang C: Identification and
evaluation of serum microRNA-29 family for glioma screening. Mol
Neurobiol. 52:1540–1546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kuo WP, Liu F, Trimarchi J, Punzo C,
Lombardi M, Sarang J, Whipple ME, Maysuria M, Serikawa K, Lee SY,
et al: A sequence-oriented comparison of gene expression
measurements across different hybridization-based technologies. Nat
Biotechnol. 24:832–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huggett JF, Foy CA, Benes V, Emslie K,
Garson JA, Haynes R, Hellemans J, Kubista M, Mueller RD, Nolan T,
et al: The digital MIQE guidelines: Minimum Information for
publication of Quantitative digital PCR experiments. Clin Chem.
59:892–902. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sackett DL, Rosenberg WM, Gray JA, Haynes
RB and Richardson WS: Evidence based medicine: What it is and what
it isnt. 1996. Clin Orthop Relat Res. 455:3–5. 2007.
|
|
57
|
Wang Z, Neuburg D, Li C, Su L, Kim JY,
Chen JC and Christiani DC: Global gene expression profiling in
whole-blood samples from individuals exposed to metal fumes.
Environ Health Perspect. 113:233–241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lampe JW, Stepaniants SB, Mao M, Radich
JP, Dai H, Linsley PS, Friend SH and Potter JD: Signatures of
environmental exposures using peripheral leukocyte gene expression:
Tobacco smoke. Cancer Epidemiol Biomarkers Prev. 13:445–453.
2004.PubMed/NCBI
|
